Geron | GERN - Equity Capital And Reserves


Geron reported $225.87M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
Bio Techne USD 2.01B 45.18M Dec/2025
Cassava Sciences USD 74.4M 7.16M Dec/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Exelixis USD 2.16B 619K Dec/2025
Genmab DKK 5.85B 96M Dec/2025
Geron USD 225.87M 22.83M Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
MacroGenics USD 55.59M 11.41M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Novavax USD -127.75M 28.92M Dec/2025